Entries of Dunst, J. on the publication server
![]() | Up a level |
Number of items: 3.
2021
Dapper, H., Belka, C., Bock, F., Budach, V., Budach, W., Christiansen, H., Debus, J., Distel, L., Dunst, J., Eckert, F., Eich, H., Eicheler, W., Engenhart-Cabillic, R., Fietkau, R., Fleischmann, D. F., Frerker, B., Giordano, F. A., Grosu, A. L., Herfarth, K., Hildebrandt, G., Kaul, D., Kölbl, O., Krause, M., Krug, D., Martin, D., Matuschek, C., Medenwald, D., Nicolay, N. H., Niewald, M., Oertel, M., Petersen, C., Pohl, Fabian, Raabe, A., Rödel, C., Rübe, C., Schmalz, C., Schmeel, L. C., Steinmann, D., Stüben, G., Thamm, R., Vordermark, D., Vorwerk, H., Wiegel, T., Zips, D. and Combs, S. E.
(2021)
Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations.
Strahlentherapie und Onkologie 198 (1), pp. 1-11.
2018
Schäfer, R., Strnad, V., Polgár, C., Uter, W., Hildebrandt, G., Ott, O. J., Kauer-Dorner, D., Knauerhase, H., Major, T., Lyczek, J., Guinot, J. L., Dunst, J., Gutierrez Miguelez, C., Slampa, P., Allgäuer, M., Lössl, K., Kovacs, G., Fietkau, R., Resch, A., Kulik, A., Arribas, L., Niehoff, P., Guedea, F., Gall, C. and Polat, B.
(2018)
OC-0326: QOL After APBI (Multicatheter Brachytherapy) Versus WBI: 5-Year Results, Phase 3 GEC-ESTRO Trial.
Radiotherapy and Oncology 127, S173-S174.
Fulltext not available.
2011
Kuhnt, T., Schreiber, A., Pirnasch, A., Hipp, M., Hass, P., Sieker, F., Engenhart-Cabillic, R., Richter, M., Delias, K. and Dunst, J.
(2011)
8501 ORAL Phase ll-trial of Concomitant Hyperfractionated-accelerated Radiotherapy (HART) With Cisplatin (Cis) Plus Cetuximab (Cet) for Locoregionally Advanced Inoperable Squamous Cell Head and Neck Cancer – Early Response and Acute Toxicities.
European Journal of Cancer 47, S543.
Fulltext not available.
